From: Prevalence of oral anticoagulant use among people with and without Alzheimer’s disease
Comorbidity (Reference: no disease) | People with AD OR (95% CI) | People without AD OR (95% CI) |
---|---|---|
Atrial fibrillation | ||
< 6 months before | 5.12 (4.90–5.36) | 7.22 (6.87–7.57) |
6–12 months before | 4.65 (4.42–4.88) | 6.55 (6.22–6.90) |
More than one year before | 4.34 (4.13–4.56) | 5.79 (5.49–6.10) |
Coronary artery bypass grafting | ||
< 6 months before | 2.68 (2.40–3.00) | 3.05 (2.79–3.35) |
6–12 months before | 1.36 (1.21–1.53) | 1.48 (1.34–1.63) |
Percutaneous coronary intervention | ||
< 6 months before | 13.58 (12.10–15.25) | 17.99 (16.35–19.79) |
6–12 months before | 4.51 (4.07–4.99) | 5.54 (5.10–6.01) |
Ischemic stroke | ||
< 6 months before | 2.40 (2.30–2.51) | 2.95 (2.81–3.10) |
6–12 months before | 2.39 (2.29–2.51) | 2.79 (2.65–2.93) |
Pulmonary embolism | ||
< 6 months before | 6.59 (5.93–7.33) | 6.82 (6.13–7.58) |
6–12 months before | 3.70 (3.35–4.10) | 3.52 (3.18–3.89) |
Deep venous thrombosis | ||
< 6 months before | 7.54 (6.81–8.35) | 5.86 (5.23–6.57) |
6–12 months before | 2.81 (2.57–3.08) | 2.35 (2.11–2.63) |
Hemorrhagic stroke | ||
< 6 months before | 1.20 (0.97–1.49) | 1.45 (1.11–1.90) |
6–12 months before | 0.95 (0.71–1.26) | 1.14 (0.84–1.54) |